HHS abandons mRNA vaccine research
One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step backward for science.”
Previous Post
Novo pushes back against obesity drug compounders as competition intensifies
Next Post
FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago